Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

France sticks to its guns on therapeutic cloning ban

This article was originally published in Clinica

Executive Summary

France is set to maintain its ban on somatic cell nuclear transfer (SCNT) for the purpose of embryonic stem-cell research - so-called therapeutic cloning, under a bill that is expected to pass through parliament by the end of the year. While the move is expected to greatly hinder France in the international biotechnology race, the country's pioneering stance does do justice to the intense public sensitivity surrounding the issue - and not only in France.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT071791

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel